Use of Vertigoheel® in patients with dizziness due to chronic cerebral ischemia (research results)

Introduction. One of the most common symptoms of chronic cerebral ischemia (CCI) is dizziness, which significantly reduces the quality of life of patients.

Aim. Тo evaluate the effects of Vertigoheel® in treatment of patients with dizziness due to CCI in comparison with betahistine and a nootropic drug (choline alfoscerate) after 3 weeks in real clinical practice.

Materials and methods. A prospective comparative observational study was conducted among 30 patients diagnosed with CCI, whose main complaint was dizziness. Patients were divided into 3 groups, 10 patients in each group: the first group received Vertigoheel® in addition to the standard treatment of CCI with choline alfoscerate; the second group took choline alfoscerate and betahistine; the third group – only choline alfoscerate. At the first visit and in dynamics (after 1 and 3 weeks), a neurological examination was performed, testing using the DHI, HADS and VAS scales.

Results. Against the background of combined treatment, a decrease in the degree of dizziness was noted to the absence in the first group (11.4 ± 8.5 points) and mild in the second (22.8 ± 10.3 points) according to the average score on the DHI scale, with an initially lower overall average score in the first group. Positive dynamics were also observed for all DHI subscales in the combined treatment groups on days 7 ± 2 and 21 ± 2. During monotherapy in the third group, no clinically significant decrease in dizziness was found with an insignificant decrease in the average score on the DHI scale and its subscales. A decrease in anxiety and depression was recorded in all groups.

Conclusions. The bioregulatory therapy product has a therapeutic effect comparable to betahistine when used in combination with a nootropic drug in patients with dizziness associated with CCI.

1. Xing Y, Si L, Zhang W, Wang Y, Li K, Yang X. Etiologic distribution of dizziness/v ertigo in a neurological outpatient clinic according to the criteria of the international classification of vestibular disorders: a singlecenter study. J Neurol. 2024;271(5):2446–2457. https://doi.org/10.1007/s00415023121663.

2. Stam H, van Vugt VA, Twisk JWR, FinneSoveri H, GarmsHomolová V, Declercq A et al. The Prevalence and Persistence of Dizziness in Older European Home Care Recipients: A Prospective Cohort Study. J Am Med Dir Assoc. 2020;21(3):338–343. https://doi.org/10.1016/j.jamda.2019.09.008.

3. Kim EJ, Song HJ, Lee HI, Kwon E, Jeong SH. Oneyear prevalence and clinical characteristics in chronic dizziness: The 20192020 Korean National Health and Nutrition Examination Survey. Front Neurol. 2022;13:1016718. https://doi.org/10.3389/fneur.2022.1016718.

4. Kammerlind AS, Peolsson A, Johansson MM. Dizziness in older persons at high risk of future hospitalization: prevalence, differences between those with and without dizziness, and effect of a proactive primary care intervention. BMC Geriatr. 2022;22(1):315. https://doi.org/10.1186/s12877022029101.

5. Burmeister J, Bock Е, Gerwig М, Frings М, ArweilerHarbeck D, Diener Н, Obermann M. Prevalence, demographics, and clinical characteristics of vertigo disorders in a specialized multidisciplinary outpatient clinic. (P1.322). Neurology. 2015;84(14_ Suppl). https://doi.org/10.1212/WNL.84.14_supplement.P1.322.

6. Wassermann A, Finn S, Axer H. AgeAssociated Characteristics of Patients With Chronic Dizziness and Vertigo. J Geriatr Psychiatry Neurol. 2022;35(4):580–585. https://doi.org/10.1177/08919887211036185.

7. Maarsingh OR, Dros J, Schellevis FG, van Weert HC, Bindels PJ, Horst HE. Dizziness reported by elderly patients in family practice: prevalence, incidence, and clinical characteristics. BMC Fam Pract. 2010;11:2. https://doi.org/10.1186/14712296112.

8. Lindell E, Kollén L, Johansson M, Karlsson T, Rydén L, Falk Erhag H et al. Benign paroxysmal positional vertigo, dizziness, and health-r elated quality of life among older adults in a population-b ased setting. Eur Arch Otorhinolaryngol. 2021;278(5):1637–1644. https://doi.org/10.1007/s00405020063571.

9. Zwergal A, Mantokoudis G, Heg D, Kerkeni H, Diener S, Kalla R et al. What is the current status of primary care in the diagnosis and treatment of patients with vertigo and dizziness in Switzerland? A national survey. Front Neurol. 2023;14:1254080. https://doi.org/10.3389/fneur.2023.1254080.

10. Saber Tehrani AS, Coughlan D, Hsieh YH, Mantokoudis G, Korley FK, Kerber KA et al. Rising annual costs of dizziness presentations to U.S. emergency departments. Acad Emerg Med. 2013;20(7):689–696. https://doi.org/10.1111/acem.12168.

11. Ruthberg JS, Rasendran C, Kocharyan A, Mowry SE, Otteson TD. The economic burden of vertigo and dizziness in the United States. J Vestib Res. 2021;31(2):81–90. https://doi.org/10.3233/VES201531.

12. Kulesh AA, Emelin AYu, Bogolepova AN, Doronina OB, Zakharov VV, Kolokolov OV et al. Clinical manifestations and issues of diagnosis of chronic cerebrovascular disease (chronic cerebral ischemia) at an early (predementia) stage. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1):4–12. (In Russ.) https://doi.org/10.14412/2074271120211-412.

13. Lokshina AB, Zakharov VV. Practical Algorithms for Management of Patients with Chronic Cerebral Ischemia. Effective Pharmacotherapy. 2019;15(19):24–28. (In Russ.) https://doi.org/10.33978/23073586201915192428.

14. Брандт Т, Дитерих М, Штрупп М. Головокружение. М.: Практика; 2009. 200 с.

15. Jiam NT, Murphy OC, Gold DR, Isanhart E, Sinn DI, Steenerson KK, Sharon JD. Nonvestibular Dizziness. Otolaryngol Clin North Am. 2021;54(5):999–1013. https://doi.org/10.1016/j.otc.2021.05.017.

16. Верткин АЛ. Головокружение. М.: Эксмо; 2017. 74 с. Режим доступа: http://gepatitnews.ru/wpcontent/uploads/2019/02/golovokruzenie.pdf.

17. Парфенов ВА, Замерград МВ, Мельников ОА. Головокружение: диагностика и лечение, распространенные ошибки. М.: МИА; 2009. 152 с.

18. Zamergrad MV. Characteristics of dizziness in elderly. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2015;115(6-2):3–8. (In Russ.). https://doi.org/10.17116/jnevro20151156238.

19. Duma SN. Treatment of vertigo in elderly patients with chronic cerebrovascular disease. Neurology, neuropsychiatry, psychosomatics. 2018;10(1):55–59. (In Russ.) https://doi.org/10.14412/2074271120181-5559.

20. Дума СН. Сосудистый психоорганический синдром в пожилом возрасте. Оценка способности к самообслуживанию по шкале инструментальной активности повседневной жизни. В: Воевода МИ, Абрамович СГ (ред.). Современные аспекты профилактики, реабилитации и курортной медицины: новые подходы и актуальные исследования. Новосибирск: Наука; 2020. 312 с.

21. Antonenko LM, Zastenskaya YeN. Persistent posturalperceptual dizziness: current approaches to diagnosis and treatment. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(4):136–140. (In Russ.) https://doi.org/10.14412/2074271120194-136140.

22. Zhivolupov SA, Samartsev IN. Modern Clinical Analysis Of Cerebrovascular Diseases: Key Issues Of Differential Diagnosis And Pathogenetic Treatment. Farmateka. 2012;(7):87–94. (In Russ.) Available at: https://pharmateca.ru/ru/archive/article/8428.

23. Chugunov AV, Kabanov AA, Kazakov A.Yu. Complex therapy of patients with chronic cerebral ischemia. Nervous Diseases. 2021;(3):25–30. (In Russ.) https://doi.org/10.24412/22260757202112351.

24. Heinle H, Tober C, Zhang D, Jäggi R, Kuebler WM. The lowdose combination preparation Vertigoheel activates cyclic nucleotide pathways and stimulates vasorelaxation. Clin Hemorheol Microcirc. 2010;46(1):23–35. https://doi.org/10.3233/CH20101330.

25. Schneider B, Klein P, Weiser M. Treatment of vertigo with a homeopathic complex remedy compared with usual treatments: a meta-a nalysis of clinical trials. Arzneimittelforschung. 2005;55(1):23–29. https://doi.org/10.1055/s-00311296821.

26. Klopp R, Niemer W, Weiser M. Microcirculatory effects of a homeopathic preparation in patients with mild vertigo: an intravital microscopic study. Microvasc Res. 2005;69(1-2):10–16. https://doi.org/10.1016/j.mvr.2004.11.005.

27. Issing W, Klein P, Weiser M. The homeopathic preparation Vertigoheel versus Ginkgo biloba in the treatment of vertigo in an elderly population: a doubleblinded, randomized, controlled clinical trial. J Altern Complement Med. 2005;11(1):155–160. https://doi.org/10.1089/acm.2005.11.155.

28. Weiser M, Strösser W, Klein P. Homeopathic vs conventional treatment of vertigo: a randomized doubleblind controlled clinical study. Arch Otolaryngol Head Neck Surg. 1998;124(8):879–885. https://doi.org/10.1001/archotol.124.8.879.